OVERVIEW

DAVA’s Think Tank on Gynecologic Cancer will be an opportunity for physicians, scientists and drug developers to shape the next wave of trials in ovarian, uterine and cervical cancer. The focus: emerging targets, phase 1 and phase 2 programs, preclinical opportunities and the biology of resistance. This will provide a platform to discuss upcoming treatment opportunities in gynecologic malignancies and to collaborate with other experts in advancing this research. Target-focused discussions will connect novel agents with better biomarkers, rational combinations and opportunities in rare histologies. Participants will identify research priorities and practical clinical-development collaborations.